5 Patents
- US126114032026Combined Pharmaceutical Composition of C-met Kinase Inhibitor and Anti-pd-l1 Antibody
TIANJIN MEDICAL UNIVERSITY CANCER INSTITUTE AND HOSPITAL
0 cites - US125277842026Combined Pharmaceutical Composition for Treating Small Cell Lung Cancer
Nanjing Shunxin Pharmaceuticals Co., Ltd. Of Chiatai Tianqing Pharmaceutical Group
0 cites - US124471542025Use of Pyrrolopyrimidine Compound for Treating Hemophagocytic Syndrome
Shouyao Holdings (Beijing) Co., Ltd.
0 cites - US124213132025Combined Pharmaceutical Composition for Treating Tumor
Nanjing Shunxin Pharmaceuticals Co., Ltd. Of Chiatai Tianqing Pharmaceutical Group
0 cites - US115541152023Quinoline Derivative for Treatment of Triple-negative Breast Cancer
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., Ltd.
0 cites